Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: A qualitative study

AIDS Patient Care and STDs

Volumn 19, Issue 8, 2005, Pages 526-537

  Kumarasamy, N ^a   Safren, Steven A ^b,c,e   Raminani, Sudha R ^b   Pickard, Robert ^b   James, Romola ^a   Sri Krishnan, A K ^a   Solomon, Suniti ^a   Mayer, Kenneth H ^b,d  

^a YRG CARE   (India)

^b Fenway Community Health   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BROWN UNIVERSITY   (United States)

^e Research Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CULTURAL FACTOR; DEVELOPING COUNTRY; DRUG COST; DRUG UTILIZATION; EDUCATION; ETHNOLOGY; FEMALE; HEALTH CARE ACCESS; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIMARY MEDICAL CARE; PRIVACY; QUALITATIVE ANALYSIS; RISK FACTOR; SEXUAL TRANSMISSION; SOCIAL ISOLATION; SOCIAL SUPPORT;

ADULT; ANTI-HIV AGENTS; DRUG COSTS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; INDIA; INTERVIEWS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PRIVACY; RISK FACTORS; SOCIAL SUPPORT;

EID: 24344503620     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2005.19.526     Document Type: Article

References (19)

1. US Agency for International Development (USAID). USAID: County Profile HIV/AIDS, India. Washington D.C.: United States Agency for International Development: Bureau for Global Health; March 2003.
2. UNAIDS. AIDS Epidemic Update: UNAIDS, December, 2003.
3. World Health Organization. India: Summary Country Profile for HIV/AIDS Treatment Scale-up. July 2004.
4. National AIDS Control Organization (NACO): Estimation of HIV Infection in India (based on HIV Sentinel Surveillance). www.naco.nic.in/indianscene/ esthiv.htm (Last accessed January 14, 2004).
5. UNAIDS. India. www.unaids.org/EN/geographical+ area/by+country/india.asp (Last accessed April 1, 2004).
6. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes inpatients with HIV infection. Ann Intern Med 2000;133:21-30.
7. Tesoriero J, French T, Weiss L, Waters M, Finkelstein R, Agins B. Stability of adherence to highly active antiretroviral therapy over time among clients enrolled in the treatment adherence demonstration project. J Acquir Immune Defic Syndr 2003;33:484-493.
8. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HTV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000;14:357-366.
9. Sackett EL, Snow JC. The magnitude of compliance and noncompliance. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, MD: Johns Hopkins Press; 1979, pp. 11-22.
10. Katzenstein DA, Lyons C, Molaghan J, Ungvarski P, Wolfe G, Williams AB. HIV therapeutics: confronting adherence. J Assoc Nurses AIDS Care 1997;8(suppl):46-58.
11. Hira S, Panchal K, Parmar P, Bhatia V. High resistance to antiretroviral drugs: The Indian experience. Int J STD AIDS 2004;15:173-177.
12. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921-929.
13. Miles MB, Humberman AM. Qualitative Data Analysis: An Expanded Sourcebook, 2nd ed. Thousand Oaks, CA: Sage Publications, 1994.
14. Safren SA, Kumarasamy N, James R, Raminani SR, Solomon S, Mayer KH. ART adherence, demographic variables, and CD4 outcome among HIV-positive patients on antiretroviral therapy in Chennai, India. AIDS Care (in press).
15. World Health Organization. Cost and cost-effectiveness of public private mix DOTS: Evidence from two pilot projects in India: 2004. Bulletin 337.
16. World Health Organization. Tuberculosis: Infection and Transmission. March 2004; Fact Sheet No. 104.
17. Lucas GM, Flexner CW, Moore RD. Directly administered antiretroviral therapy in the treatment of HIV infection: Benefit or burden? AIDS Patient Care STD 2002;16:527-535.
18. Safren SA, Otto MW, Worth JL. Life-Steps: Applying Cognitive-Behavioral Therapy to Patient Adherence to HIV Medication Treatment. Cogn Behav Pract 1999;6:332-341.
19. Safren SA, Otto MW, Worth J, et al. Two strategies to increase adherence to HIV antiretroviral medication: Life-Steps and medication monitoring. Behav Res Ther 2001;39:1151-1162.